Stay updated on Sitagliptin in GVHD: Grade 3-4 Clinical Trial
Sign up to get notified when there's something new on the Sitagliptin in GVHD: Grade 3-4 Clinical Trial page.

Latest updates to the Sitagliptin in GVHD: Grade 3-4 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe history shows a new Revision: v3.3.3 was added, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed, indicating site maintenance updates rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedAdded Revision: v3.3.2 to the record history and removed Revision: v3.3.1.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision history shows addition of version v3.3.1 and removal of v3.2.0 in the study record. This is routine record maintenance; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedRemoved the lapse-in-funding notice banner from the page, leaving only the standard study history and status sections. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check60 days agoChange DetectedVersion 2 (2021-01-29) updates the Record History with changes to Recruitment Status and Study Status for this trial.SummaryDifference0.1%

- Check89 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference13%

Stay in the know with updates to Sitagliptin in GVHD: Grade 3-4 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitagliptin in GVHD: Grade 3-4 Clinical Trial page.